Are tumors causing stricture of bile duct always malignant?

Feb 22, 2008

The benign biliary tract tumor is rarely found in clinical practice. One case of bile duct adenomyoma was recently reported in the January 28 issue of the World Journal of Gastroenterology. This paper cited studies on how to differentiate it pre-operatively, and may be helpful to surgeons and beneficial to patients.

The paper described a patient who presented to Dr. Gui-Ming Shu of Tianjin Third Central Hospital, affiliated to Tianjin Medical University, China, in 2005. The patient presented with yellow skin and sclera and complained of itching for two months. He suffered from anorexia and occasional nausea. Tea colored urine, yellowish white feces and weight loss of 2.5 kg were found.

Nothing special was found in the physical examination except the yellowish skin and sclera. Then Computerized Tomography (CT), Magnetic resonance cholangiopancreatography (MRCP), ultrasonography and blood biochemistry examinations were performed, presenting a suspected tumor of the distal bile duct. Later, the patient was treated successfully by pancreaticoduodenectomy.

Histologically, the tumor was adenomyoma, a seldom found benign disease of the bile duct. The patient has been well without any evidence of recurrence for 12 months since his operation.

Source: World Journal of Gastroenterology

Explore further: Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC

add to favorites email to friend print save as pdf

Related Stories

Consortium finds chronic liver cirrhosis clues

Mar 13, 2011

Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients. The new study identifies 15 genetic regions ...

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

5 hours ago

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

9 hours ago

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

Immunotherapy set to revolutionise cancer treatment

11 hours ago

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.